A global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products.


Updates from The Motley Fool

Latest updates on Sanofi from Fool.com.  The Fool has written over 500 articles on Sanofi.
3 Reasons To Buy Biogen

Drugs in Biogen's pipeline and top-shelf financials could mean that Biogen's future may not be as...



Stock Performance

View Interactive SNY Charts
Sponsored by

Key Data Points

Primary metrics and data points about Sanofi.
Current Price: $49.95
Prev Close: $49.08
Open: $50.08
Bid: $49.46
Ask: $50.26
Day's Range: $49.94 - $50.25
52wk Range: $36.81 - $50.25
Volume: 854,695
Avg Vol 923,376
Market Cap: $125B
P/E (ttm): 26.39
EPS (ttm): $0.00
Div & Yield: $1.64 (2.2%)

Company Rating

What our community thinks about Sanofi.
CAPS Rating 5 out of 5
 
909 Outperform
41 Underperform
CAPS All Stars
 
205 Outperform
8 Underperform

How do you think Sanofi will perform against the market?



You pick for Sanofi is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Olivier Brandicourt, CEO

73% Approve

Based on 151 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Sanofi.

A global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers